Cygnus Options to Convert at 0.06 Ratio Under Acquisition Scheme
Cygnus Metals secures ASX waivers allowing cancellation or transfer of options without shareholder vote as part of Central Asia Metals acquisition plan.
- ASX waivers granted for Cygnus Options cancellation and transfer
- Options replaced by new Central Asia Metals options at 0.06 ratio
- Waivers conditional on scheme approval by shareholders and court
- Scheme involves CAML acquiring all Cygnus shares
- Cancellation or transfer effective only if scheme becomes binding
ASX Approves Waivers to Facilitate Option Treatment in Acquisition
Cygnus Metals Limited (ASX:CY5) has received key regulatory waivers from the Australian Securities Exchange (ASX) to allow the cancellation or transfer of its outstanding options without the need for shareholder approval. This development is a crucial step in advancing the proposed scheme of arrangement under which Central Asia Metals PLC (AIM:CAML) will acquire all issued shares in Cygnus.
The waivers specifically relate to ASX Listing Rules 6.23.2 and 6.23.4, which ordinarily require shareholder approval for cancelling or amending option terms. The ASX has granted these waivers on the condition that full details of the option treatment are disclosed in the scheme booklet and that the scheme is approved by both Cygnus shareholders and the court, with the court's orders lodged with the Australian Securities and Investment Commission (ASIC).
Options to Convert into New CAML Options on Implementation
Under the terms of the scheme, all Cygnus Options on issue at the implementation date will either be cancelled or transferred to CAML (or its nominee). Option holders are expected to enter into deeds agreeing to this treatment, receiving 0.06 new options in CAML for each Cygnus Option held. This exchange ratio reflects the agreed terms of the acquisition and will only take effect if the scheme becomes effective according to the Corporations Act.
If the scheme does not proceed, the Cygnus Options will remain unchanged, preserving their existing terms and rights.
Implications for Shareholders and Next Steps
The ASX waivers streamline the process by removing the need for a separate shareholder vote on the option cancellation or transfer, reducing potential delays in executing the scheme. However, the ultimate implementation hinges on the scheme receiving the requisite shareholder and court approvals.
Investors should watch for the release of the scheme booklet, which will provide comprehensive details on the option treatment and the broader acquisition terms. The outcome of the shareholder meeting and court hearing will be pivotal in determining whether the scheme proceeds as planned.
Bottom Line?
The ASX waivers clear a procedural hurdle for Cygnus's acquisition but leave key approvals as the next critical milestones.
Questions in the middle?
- Will the scheme gain the necessary shareholder and court approvals to become effective?
- How will the 0.06 exchange ratio for options impact the value perception among Cygnus option holders?
- What are the potential financial implications for Cygnus shareholders if the scheme fails to proceed?
